These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

832 related items for PubMed ID: 15709166

  • 1. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 2. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct 01; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade.
    Gastman BR, Yin XM, Johnson DE, Wieckowski E, Wang GQ, Watkins SC, Rabinowich H.
    Cancer Res; 2000 Dec 15; 60(24):6811-7. PubMed ID: 11156370
    [Abstract] [Full Text] [Related]

  • 6. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM, Wang Y, Weber RL, Sperfslage BJ, Lou K, Crossland J, Hua DH, Perchellet JP.
    Biochem Pharmacol; 2004 Feb 01; 67(3):523-37. PubMed ID: 15037204
    [Abstract] [Full Text] [Related]

  • 7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 01; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 8. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ, Anel A, Gamen S, Monle n I, Lasierra P, Larrad L, Piñeiro A, Alava MA, Naval J.
    J Immunol; 1999 Aug 01; 163(3):1274-81. PubMed ID: 10415024
    [Abstract] [Full Text] [Related]

  • 9. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 01; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 13. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.
    Takahashi A, Kono K, Amemiya H, Iizuka H, Fujii H, Matsumoto Y.
    Clin Cancer Res; 2001 Jan 01; 7(1):74-80. PubMed ID: 11205921
    [Abstract] [Full Text] [Related]

  • 14. Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?
    Bohana-Kashtan O, Civin CI.
    Clin Cancer Res; 2005 Feb 01; 11(3):968-70. PubMed ID: 15709161
    [No Abstract] [Full Text] [Related]

  • 15. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
    Jørgensen A, Wiencke AK, la Cour M, Kaestel CG, Madsen HO, Hamann S, Lui GM, Scherfig E, Prause JU, Svejgaard A, Odum N, Nissen MH, Röpke C.
    Invest Ophthalmol Vis Sci; 1998 Aug 01; 39(9):1590-9. PubMed ID: 9699548
    [Abstract] [Full Text] [Related]

  • 16. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
    Crowe DL, Boardman ML, Fong KS.
    Anticancer Res; 1998 Aug 01; 18(5A):3163-70. PubMed ID: 9858879
    [Abstract] [Full Text] [Related]

  • 17. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
    Dick AD, Siepmann K, Dees C, Duncan L, Broderick C, Liversidge J, Forrester JV.
    Invest Ophthalmol Vis Sci; 1999 Sep 01; 40(10):2258-67. PubMed ID: 10476791
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epithelial ovarian cancer cells secrete functional Fas ligand.
    Abrahams VM, Straszewski SL, Kamsteeg M, Hanczaruk B, Schwartz PE, Rutherford TJ, Mor G.
    Cancer Res; 2003 Sep 01; 63(17):5573-81. PubMed ID: 14500397
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.